In 2021, BPI was served with a Form 483 letter from the FDA, alleging the company was using improper equipment and procedures and failing to vet suppliers adequately
Abbott CA, Vileikyte L, Williamson S, and et al
Start with the best online GLP-1 programs weve rated for safety, coverage clarity, and ease of use
Outcomes of interest included response to controlled ovarian stimulation, embryo fertilization rate, implantation rate, live birth rate, change in liver enzyme levels or hepatitis viral load
But it doesnt have the same name recognition or popularity as the newer GLP-1 drugs for a very simple reason: It doesn't work as well, can cause more severe side effects, and patients have to inject it daily rather than weekly